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Background: Protein phosphates 4 (PP4), encoded by the ppp4c gene, is a ubiquitously expressed phosphatase
that has been implicated in the regulation of cytokine signaling and lymphocyte survival; recent reports suggest
that PP4 may be involved in pre-TCR signaling and B cell development. However, whether PP4 also modulates the
functions of peripheral T cells has not been investigated due to the lack of a suitable in vivo model. Treg cells are a
specialized subset of CD4 helper T cells that can suppress the proliferation of activated effector T cells. In the absence of
this negative regulation, autoimmune syndromes and inflammatory diseases, such as human Crohn’s disease, will arise.
Results: In this report, we generated mice with T cell-specific ablation of the ppp4c gene (CD4cre:PP4f/f) and a
Foxp3-GFP reporter gene to examine the roles of PP4 in Treg development and function. Characterizations of
the CD4cre:PP4f/f mice showed that PP4 deficiency induced partial αβ T lymphopenia and T cell hypo-proliferation.
Further analyses revealed significant reductions in the numbers of thymic and peripheral Treg cells, as well as in the
efficiency of in vitro Treg polarization. In addition, PP4-deficient Treg cells exhibited reduced suppressor functions that
were associated with decreased IL-10, CTLA4, GITR and CD103 expression. More interestingly, the CD4cre:PP4f/f mice
developed spontaneous rectal prolapse and colitis with symptoms similar to human Crohn’s disease. The pathogenesis
of colitis required the presence of commensal bacteria, and was correlated with reduced Treg cells in the gut.
Nevertheless, PP4-deficient Treg cells were still capable of suppressing experimental colitis, suggesting that multiple
factors contributed to the onset of the spontaneous colitis.
Conclusions: While the molecular mechanisms remain to be investigated, our results clearly show that PP4 plays a
non-redundant role for the differentiation, suppressor activity and gut homeostasis of Treg cells. The onset of
spontaneous colitis in the CD4cre:PP4f/f mice further suggests that PP4 is essential for the maintenance of protective
gut immunity. The CD4cre:PP4f/f mice thus may serve as a good model for studying the interactions between Treg
cells and gut commensal bacteria for the regulation of mucosal immunity.Background
Protein phosphatase 4 (PP4/PPX) is a ubiquitously
expressed serine/threonine phosphatase that belongs to
the PP2A/PP4/PP6 family [1]. Human and mouse PP4
nucleotide sequences, encoded by the ppp4c genes, are
well-conserved with identical translated amino acid se-
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unless otherwise stated.the function of PP4. Indeed, the embryonic lethality of
ppp4c-knockout mice suggests that PP4 is essential for
fetal development [2]. Initially identified as a mediator of
TNFα signalings through the activation of JNK [3], PP4
is now implicated in many biological processes such as
apoptosis [4], microtubule organization [5] and DNA
double strand break repair [6,7]. Nevertheless, while
these reports convincingly identify possible functions of
PP4, their conclusions are often shadowed by the use of
siRNA and chemical inhibitors that may carry off-target
effects, particularly on PP2A and PP6.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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in vivo, we generated mice carrying a floxed ppp4c allele
(PP4f ) by embryonic stem cell targeting, and introduced
proximal Lck promoter-driven Cre recombinase trans-
gene (Lckcre) to mediate T cell-specific deletion of ppp4c
(Lckcre:PP4f/f ). Analyses of the Lckcre:PP4f/f mice reveal
that PP4 deficiency blocks pre-TCR signaling and in-
duces apoptosis of immature thymocytes [2]. Recent
data also show that PP4 can regulate apoptosis in pri-
mary human T cells [4]. These results thus suggest that
PP4 may be an important mediator of T cell expansion
and survival. Further analysis of the functions of PP4 in
peripheral T cells, however, is prohibited by the absence
of mature T cells in the Lckcre:PP4f/f mice [2].
A specialized subset of CD4 helper cells constitutively
expresses CD25 on their surface, and is termed regula-
tory T (Treg) cells for their ability to suppress the prolif-
eration of neighboring T cells [8]. Treg cells develop in
the thymus (known as nTreg), but can also be induced
from naïve T cells in vitro under proper polarizing con-
ditions (known as iTreg). The differentiation and func-
tion of Treg cells are critically enforced by the master
transcription factor Foxp3 and its downstream genetic
programs [9]. Recent reports, however, suggest that the
lineage stability and function of Treg cells are also critic-
ally controlled by epigenetic regulations on Foxp3 and
other Treg-related genes [10,11]. Regardless of how the
Treg lineage is maintained, proper Treg function is piv-
otal for the establishment of a protective immune sys-
tem, as the deficiency of foxp3 gene ablates Treg cells
and causes multiple autoimmune syndromes [12]; the
deletion of foxp3 in adult Treg cells also induces cata-
strophic autoimmunity [13].
Inflammatory bowel disease (IBD) is one of the human
disorders that are considered to have immunopathogen-
esis origin [14]. IBD can be further categorized into
Crohn’s disease and ulcerative colitis, in which Crohn’s
disease is thought to be caused by deregulated Th1/
Th17 inflammatory response, while imbalanced antibody
reaction is considered to be upstream of the exacerba-
tion of ulcerative colitis [14]. Still, non-immune compo-
nents, including alterations in commensal microbiota,
epithelial barrier integrity, and gut exocrine function all
contribute to the onset of IBD [14,15]. With this com-
plex nature of IBD in mind, it is not surprising that
multi-pronged approaches are required to study the
many aspects of IBD pathogenesis. In this regard, many
spontaneous and inducible IBD mouse models have been
developed to investigate the etiology of IBD in vivo [15],
of which several reports have indicated Treg cells to be
an important regulator of IBD [16-18].
To study the functions of PP4 in Treg cells, we
crossed the PP4f allele with CD4cre transgene (CD4cre)
[19] and the Foxp3-GFP reporter knock-in gene [20] togenerate the CD4cre:PP4f/f:Foxp3-GFP+ mice. Character-
izations of these mice revealed important modulatory
roles of PP4 on Treg differentiation, homeostasis and
function. Furthermore, the spontaneous rectal prolapse
and colitis that developed in the CD4cre:PP4f/f:Foxp3-
GFP+ mice further indicated an immune regulatory func-
tion of PP4 for maintaining the immunological balance in
the gut.
Results
PP4 deficiency induces partial αβ T cell lymphopenia
Our previous analyses of the Lckcre:PP4f/f mice showed
that the ablation of PP4 resulted in near-complete lym-
phopenia in the periphery [2]. To examine whether per-
ipheral T cells could develop normally in the absence of
PP4, we analyzed 4-6 wk old CD4cre:PP4f/f mice, and
found that they had normal numbers of total splenocytes
(Figure 1A). Closer examinations, however, revealed sig-
nificant reductions in the percentages of CD4+ (~50% of
PP4f/f control) and CD8+ (~30% of PP4f/f control) T cells
(Figure 1B, left panel). These reductions were mostly at-
tributed to the decrease in αβ T cells (Figure 1B, middle
panel), and were accompanied by compensatory in-
creases in the percentages of γδ T cells and CD4−CD8−
T cells in the CD4cre:PP4f/f mice (Figure 1B, middle
and right panels). To see if these reductions were limited
to specific αβ T cell lineages or activation status, we further
subsetted CD4cre:PP4f/f αβ T cells by markers such as
CD62-L, CD45RB (naïve T cells) and CXCR5 (follicular
helper cells), and found that the expression of these
markers in both CD4+ and CD8+ cells was similar to those
from WT littermates (p > 0.05, Figure 1C).
PP4 is essential for the differentiation, function and gut
homeostasis of Treg cells
Treg cells are essential for maintaining a balanced im-
mune system [21]; in addition, their importance in gut
immunity has been demonstrated in adoptive transfer
models [16] and in gene-deficient mice [22]. To assess
the roles of PP4 in Treg development and function,
we crossed the CD4cre:PP4f/f mice with mice carrying
the Foxp3-GFP reporter gene [20] (hereon referred as
CD4cre:PP4f/f:Foxp3-GFP+ mice). Flow cytometry ana-
lyses showed that the percentage of CD25+Foxp3-GFP+
cells in CD4 single-positive (CD4SP) thymocytes was
reduced by 2-fold in the CD4cre:PP4f/f:Foxp3-GFP+ mice
(Figure 1D; p < 0.001); similar reductions were also found
in splenic CD4 T cells (Figure 1E; p = 0.037), but not in the
lymph nodes (LNs) (Figure 1E). To test whether the dele-
tion of ppp4c gene impacted Treg polarization in vitro,
WT or CD4cre:PP4f/f CD4+CD62-L+ cells were activated
under Treg-polarizing condition; the results showed that
the induction of Foxp3-GFP+ cells was significantly re-







Figure 1 (See legend on next page.)
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Figure 1 The ablation of PP4 induces partial αβ T lymphopenia and hampers Treg differentiation in vivo and in vitro. A, Splenocytes
from 4-6 wk old mice were enumerated (n = 6-10). B-C, splenocytes were stained for various T cell markers, followed by flow cytometry analyses
for the composition of CD4+, CD8+, αβ T, γδ T or CD4−CD8− cells in total splenocytes (n = 7-12) (B); alternatively, the expression of various lineage
or activation markers on gated CD4+ or CD8+ cells was analyzed (n = 3-7) (C). D, Thymocytes were analyzed for the percentages of Foxp3-GFP+ cells
in gated CD4SP population. Representative flow cytometry results are shown (left panels). Statistical analyses results are shown (right panel;
n = 8 ~ 12). E, CD4-gated splenocytes were analyzed as in A. Representative flow cytometry results are shown (left panels). Statistical analyses
results are shown (Right panel; n = 14 ~ 19). F, Naïve CD4+CD62-L+ cells were MACS-purified and activated under Treg polarization condition.
Cells were harvested on d 3 to analyze Foxp3-GFP expression in CD4-gated population. Representative flow cytometry results and statistical
analyses are shown (E = 4, n = 7). G, Splenic CD4+Foxp3-GFP+ Treg cells were sorted from 6 or 12 wk old mice. DNA from these cells was analyzed
by qPCR to measure the extents of ppp4c gene deletion (see schematics for primer design and deletion efficiency calculation; left panel). Statistical
analyses results are shown (right panel; n = 2). See Additional file 1: Figure S1 for flow cytometry gating strategies.
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using genomic DNA from sorted splenic CD4+Foxp3-
GFP+ cells to assess the efficiency of ppp4c deletion
in the CD4cre:PP4f/f:Foxp3-GFP+ mice; the results showed
that the ppp4c gene was indeed deleted in >85% of the
Treg cells (Figure 1G). Western analyses of purified T cells
also confirmed the deficiency of PP4 in the CD4cre:PP4f/f
mice (Additional file 1: Figure S2A). These findings thus
suggest that PP4 is essential for the differentiation and
homeostasis of Treg cells in vivo.
To examine whether PP4 deficiency also altered the
ability of Treg cells to suppress T cell proliferation, WT-
or CD4cre:PP4f/f-Foxp3-GFP+ cells were sorted and co-
cultured with activated WT responder T cells. Analyses
of the responder cell proliferation showed that CD4cre:
PP4f/f Treg cells were significantly less effective in sup-
pressing the proliferation of CD4 responders (Figure 2A,
left panel; p = 0.007-0.02); the suppression of CD8 re-
sponders by CD4cre:PP4f/f Treg cells was also less effect-
ive, as indicated by the reduced suppression efficiency
at all Treg : responder ratios (Figure 2A, right panel;
p > 0.05). Since the suppressor functions of Treg cells are
thought to be mediated by cytokines such as TGFβ and
IL-10, as well as by surface receptors such as CD25,
CTLA4 and GITR [9], we thus performed quantitative
PCR (qPCR) to examine the expression of these genes.
The results showed that PP4-deficient Treg cells exhibited
significantly reduced transcription of il10 and slightly less
transcription of ctla4 (Figure 2B); the mRNA levels of
tgfb1 and foxp3 were not clearly altered (Figure 2B).
Meanwhile, flow cytometry analyses showed that PP4-
deficient Treg cells expressed slightly higher level of CD25
(p = 0.0004) but normal levels of CD39, CD223, and Foxp3
(Figure 2C); more importantly, the levels of CTLA4
(p = 0.04) and GITR (p < 0.0001) were both significantly
reduced in the CD4cre:PP4f/f Treg cells (Figure 2C). The
reduced suppressor function of PP4-deficient Treg cells
may thus be attributed to the decreased IL-10, CTLA4,
and GITR expressions.
In addition to the thymus and spleen, we also found
reduced numbers of Foxp3-GFP+ Treg cells in the gut ofCD4cre:PP4f/f mice: while the percentages of Foxp3-GFP+
Treg cells were relatively unchanged in the mesenteric
lymph nodes (MLN) and Peyer’s patches, the numbers of
Foxp3-GFP+ Treg cells in the lamina propria lymphocyte
(LPL) (p = 0.02) and intra-epithelial lymphocyte (IEL)
(p = 0.01) subsets were both significantly reduced in the
CD4cre:PP4f/f mice (Figure 3A). qPCR of sorted CD4cre:
PP4f/f MLN Foxp3-GFP+ Treg cells again confirmed the ef-
ficient deletion of the ppp4c gene in these cells (Figure 3B).
That the numbers of PP4-deficient Treg cells were reduced
in the LPL and IEL but not in the MLN implicate a poten-
tial homing defect of PP4-deficient Treg cells. Indeed,
when circulating PP4-deficient Foxp3-GFP+ Treg cells in
the peripheral LN were analyzed, we found significant re-
ductions in both the transcription (Figure 3C) and surface
expression (Figure 3D) of CD103 (αE integrin), which was
reported to be important for gut-homing of lymphocytes
[23] and Treg-mediated suppression of experimental colitis
[24]. Combined with the reduced Treg cell numbers and
ineffective suppressor function, our results suggest that
PP4 plays a non-redundant role in the differentiation, func-
tion, and gut homeostasis of Treg cells.
Spontaneous rectal prolapse and colitis develop in the
CD4cre:PP4f/f mice
When maintaining the CD4cre:PP4f/f mouse colony, we
found that, by the age of 15 wk old, ~60% of the
CD4cre:PP4f/f mice developed spontaneous rectal pro-
lapse (Figure 4A-B) that was rarely (<0.5%) observed in
the PP4f/f and Lckcre:PP4f/f mice housed in the same
room. The rectal prolapse was accompanied by mild
splenomegaly and lymphoadenopathy (Figure 4C) that
were occasionally observed in prolapse-free CD4cre:
PP4f/f mice. Histological examination of the colons from
prolapsed CD4cre:PP4f/f mice showed typical signs of
colitis, such as submucosa thickening, epithelial hyper-
plasia, loss of goblet cells, and mononuclear cell infil-
tration (Figure 4D-E). To examine if the inflammation also
encompassed the small intestine, we isolated IEL and LPL
from the small intestines of PP4f/f littermates, prolapse-free
CD4cre:PP4f/f, and prolapsed CD4cre:PP4f/f mice, and



















































































































































































































































Figure 2 PP4 deficiency impairs Treg suppression activity. A, CD4+Foxp3-GFP+ Treg cells (CD45.1−CD90.1−) were purified by sorting and
co-cultured at titrating ratios with fixed numbers of CFSE-labeled WT responder CD4 and CD8 T cells (CD45.1−CD90.1+) and irradiated WT APC
(CD45.1+CD90.1−). Division index of CD90.1+ CD4 and CD8 responder T cells was calculated from their CFSE patterns on d 3. Treg-mediated
suppression was calculated by the division index differences between Treg-added samples and responder-only control. Relative suppression
efficiencies were plotted after normalized to that of WT Treg cells at 1:1 ratio (E = 3, n = 4-5 group except for CD4cre:PP4f/f Treg at 1:1 ratio,
for which n = 1 due to extremely low number of Foxp3-GFP+ cells in the CD4cre:PP4f/f mice). B, LN CD4+Foxp3-GFP+ Treg cells were sorted by flow
cytometry. cDNA was synthesized using RNA from these cells and used for qPCR analyses. Relative mRNA level normalized to β actin results are
shown (n = 2). C, LN CD4+Foxp3-GFP+ Treg cells were analyzed for various Treg markers and Foxp3-GFP expression. Representative plots on gated
CD4+Foxp3-GFP+ cells are shown. Statistical analyses of the mean fluorescence levels are also shown (inserts; n = 8 ~ 10). See Additional file 1:
Figure S1 for flow cytometry gating strategies.
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such as IFNγ, IL-6, and IL-17A. No significant difference
was found between prolapse-free CD4cre:PP4f/f mice and
PP4f/f littermates (Figure 4F-G). In contrast, prolapsed
CD4cre:PP4f/f mice exhibited elevated percentages of
IFNγ+, IL-6+ and IL-17A+ T cells, particularly in the CD8+
IEL compartment (p < 0.001 ~ 0.02, Figure 4G), implicating
the presence of mucosal inflammation in the small intes-
tine. The gut inflammation in prolapsed CD4cre:PP4f/f
mice thus bears a resemblance to human Crohn’s disease
by the transmural pathology and the presence of inflamma-
tory T cells in the upper gut [25].
The spontaneous prolapse is not preceded by
accumulation of pro-inflammatory T cells in the gut
While the reduced numbers of gut Treg cells (Figure 3A)
correlates with the onset of colitis and rectal prolapse,potential alterations in the composition or function LPL
an IEL may also contribute. In this regard, we analyzed
LPL and IEL cells for the expression of various lympho-
cyte markers. The results showed that, similar to the
spleen and LN, LPL and IEL of prolapse-free CD4cre:
PP4f/f mice showed reduction in αβ T cells (Figure 5A-B,
left panels); the onset of prolapse had no effect on this
reduction (Figure 5A-B, left panels). When further sub-
setted based on the expression of Thy1 (CD90), we ob-
served a slight increase in the percentages of Thy1+TCRδ+
LPL and Thy1+TCRβ+ or Thy1+TCRδ+ IEL (Figure 5A-B,
middle panels). However, the most significant alterations
were the accumulation of CD49b+ NK/NKT cells and the
accompanying reduction of CD3ε+ T cells in the IEL com-
partment of prolapsed CD4cre:PP4f/f mice (Figure 5B,
right panels). In parallel, we isolated IEL T cells from











































































































































Figure 3 Defective gut homeostasis of Treg cells in the CD4cre:PP4f/f mice. A, MLN, Peyer’s patch (PP), LPL, and IEL cells were isolated and
analyzed for the percentages of Foxp3-GFP+ cells in gated CD4 T cell populations (n = 6 ~ 16). B, MLN CD4+Foxp3-GFP+ Treg cells from MLN were
MACS-purified from 6 or 12 wk old mice and analyzed for ppp4c deletion efficiency as in Figure 1G (n = 3). C, RNA from sorted LN CD4+Foxp3-GFP+
cells were analyzed as in Figure 2B. Relative CD103 mRNA levels normalized to β actin results are shown (n = 2). D, LN CD4+Foxp3-GFP+ Treg cells
were analyzed as in Figure 2C. A representative CD103 plot in gated CD4+Foxp3-GFP+ population is shown (left panel). Statistical analyses of the
mean fluorescence levels are also shown (right panel; n = 8 ~ 10). See Additional file 1: Figure S1 for all flow cytometry gating strategies.
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deficient IEL T cells preferentially secreted inflammatory
cytokines. The analyses revealed similar productions of
IL-1α, IL-2, IL-6, IL-17A, IFNγ and TNFα between
WT and PP4-deficient IEL T cells (Additional file 1:
Figure S2B). The reduced number of IEL CD3ε+ T cells in
prolapse-free CD4cre:PP4f/f mice and their normal cyto-
kine productions thus suggest that the ablation of PP4
does not induce the accumulation of pro-inflammatory
T cells in the gut to cause colitis onset. Instead, the ac-
cumulation of IFNγ+, IL-6+ and IL-17A+ IEL cells in
prolapsed CD4cre:PP4f/f mice (Figure 4G) may only
occur during the latter phase of colitis pathogenesis.
PP4-deficient T cells are hypo-responsive to antigen
stimulation, ineffective for Th17 polarization, and incapable
of inducing experimental colitis
We next immunized the CD4cre:PP4f/f mice with key-
hole limpet hemocyanin (KLH) to assess whether the de-
letion of PP4 induced novel hyper-reactive T cells. The
results showed that, contrary to the prediction based on
the inflammatory nature of colitis, CD4cre:PP4f/f T cells
were actually hypo-responsive to restimulation by KLH
(Figure 6A). In addition, the secretion of IL-2 and IFNγ
was also reduced, while the production of IL-4 and IL-10
were undetectable, in PP4-deficient T cells (Figure 6B).Hinging on these altered cytokine productions, Th1, Th2
and Th17 polarizations were compared between control
and CD4cre:PP4f/f T cells. Interestingly, the efficiency of
Th1 and Th2 polarization was similar between the two
populations; however, PP4-deficient T cells differentiated
into IL-17A-secreting Th17 cells with much reduced effi-
cacy (p = 0.007, Figure 6C). Finally, to test if the ablation
of PP4 enhanced the overall colitogenic ability of per-
ipheral T cells, we adoptively transferred WT or PP4-
deficient CD4+CD45RBhi cells into RAG1-/- recipients to
induce experimental colitis (Figure 6D) [26]. While WT
cells successfully induced wasting syndromes in the re-
cipients, PP4-deficient CD4+CD45RBhigh cells failed to do
so (Figure 6E); these results could potentially be linked
with the hypo-proliferation (Figure 6A) or reduced Th17
polarization (Figure 6C) of PP4-deficient T cells. Regard-
less, these data argue against the induction of novel colito-
genic T cells by PP4 deficiency, and suggest that other
factors are responsible for inducing the onset of the spon-
taneous colitis in these mice.
The spontaneous colitis in the CD4cre:PP4f/f mice requires
commensal bacteria and is heralded by systematic
granulocyte infiltration
To gain more insight into the pathophysiological mecha-







Figure 4 CD4cre:PP4f/f mice develop spontaneous rectal
prolapse and colitis with symptoms resembling Crohn’s
disease. A, Visualization of rectal prolapse in the CD4cre:PP4f/f mice.
Results from controls PP4f/f mice are also shown. B, Age of prolapse
onset in the CD4cre:PP4f/f mice (n = 64). C, Mild splenomegaly and
LN adenopathy in prolapsed CD4cre:PP4f/f mice. Results from controls
PP4f/f mice are also shown. D-E, Haematoxylin and eosin staining of
formaldehyde-fixed longitudinal (D) or transverse (E) section of normal
PP4f/f (left column) or prolapsed CD4cre:PP4f/f colons (right column) are
shown. Bars indicate 1000 μm (40X), 400 μm (100X) and 200 μm (200X)
respectively. F-G, LPL (F) and IEL (G) cells were isolated and analyzed by
flow cytometry for intracellular cytokines. Statistical analysis results on
gated CD4+ (left panels) or CD8+ (right panels) cells are shown (n= 5-7).
See Additional file 1: Figure S1 for flow cytometry gating strategies.
Liao et al. Cell & Bioscience 2014, 4:25 Page 7 of 14
http://www.cellandbioscience.com/content/4/1/25mice, we conducted a series of experiments to investi-
gate the associated factors. First, we found that the
inflammation in the gut is preceded by the accumu-
lation of CD4−CD8−B220−Gr1+ granulocytes in the
spleen, LN, and MLN in prolapse-free CD4cre:PP4f/f mice
(Figure 7A). When colitic CD4cre:PP4f/f mice were treated
with broad-spectrum antibiotics, the colitis pathology and
weight loss were effectively reversed (Figure 7B). These
data suggest that the spontaneous colitis in the CD4cre:
PP4f/f mice may be caused by the failure to contain com-
mensal bacteria in the gut. Treatment of WT and CD4cre:
PP4f/f mice with dextran sodium sulfate (DSS), however,
caused similar acute colitis symptoms in both mice
(Figure 7C), and suggested that PP4 deficiency likely
did not directly disrupt the gut barrier to predispose the
CD4cre:PP4f/f mice to mucosal inflammation. Lastly, to
test whether the functional defect in CD4cre:PP4f/f Treg
cells was the predominant cause for the spontaneous col-
itis in the CD4cre:PP4f/f mice, we co-transferred WT or
CD4cre:PP4f/f Treg cells with WT CD4+CD45RBhigh T
cells into RAG1-/- recipients (Figure 7D). Surprisingly,
the results showed that CD4cre:PP4f/f Treg cells were still
capable of suppressing the induction of experimental col-
itis (Figure 7E, top panel) despite their reduced in vitro
suppressor activity (Figure 3A). Reducing the number
of co-transferred Treg cells yielded similar outcomes
(Figure 7E, bottom panel). Together, these data suggest
that the onset of spontaneous colitis in the CD4cre:PP4f/f
mice cannot be attributed solely to the functional defects
of Treg cells, but is likely orchestrated by additional fac-
tors, such as the gut homeostasis of Treg cells, the infiltra-
tion of commensal bacteria, and the activation of innate
immunity.
Discussion
In this report, we have described the spontaneous pro-
lapse and colitis in mice with T cell-specific ablation of
PP4, the CD4cre:PP4f/f mice. What are the factors that
might have contributed to the onset of colitis in these
mice? Altered Treg cell functions (Figure 2) are likely a
AB
Figure 5 PP4 deficiency reduces LPL and IEL αβ T cell numbers without significantly impacting their subset distributions. A-B, LPL (A)
and IEL (B) were isolated and analyzed for the expression of various markers by flow cytometry. Results on total (left panels), TCRβ/TCRδ-gated
(middle three panels), or B220−Gr1−-gated (right three panels) cells are shown (n = 2-8). See Additional file 1: Figure S1 for flow cytometry
gating strategies.
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Commensal bacteria are clearly a prerequisite, as indi-
cated by the amelioration of colitis following antibiotic
treatment (Figure 7B). The accumulation of granulocytes
in prolapse-free CD4cre:PP4f/f mice (Figure 7A) and the
increased number of pro-inflammatory IEL T cells in
prolapsed CD4cre:PP4f/f mice (Figure 4G) further impli-
cate the involvement of innate and adaptive, respectively,
anti-commensal immune responses in the gut. Finally,
the seemingly contradictory hypo-responsiveness of PP4-
deficient T cell to antigen stimulation (Figure 6A-B) may
actually contribute to the onset of colitis by preventing
the clearance of infiltrating commensal bacteria. While it
is difficult to quantify the relative contributions of the in-
dividual factors, these observations are consistent with the
core scenario that uncontrolled activation of mucosal in-
nate and adaptive immune cells, caused by defective Treg
suppression, results in persistent, commensal-dependent
gut inflammation that eventually breaches the mucosal
barrier for the onset of colitis in the CD4cre:PP4f/f mice.
Although our data fit nicely into this working model,
the clear disparity in the colitis incidence rates of
Lckcre:PP4f/f (<0.5%) and CD4cre:PP4f/f (>60%) mice
needs to be addressed. In this regard, a major difference
between these mice is that the Lckcre:PP4f/f mice exhibit
severe lymphopenia [2], while the CD4cre:PP4f/f mice
contain reduced but substantial number of peripheral T
cells (Figure 1B-C). The residual PP4-deficient T cells in
the CD4cre:PP4f/f mice may thus be essential for the T
cell component of the inflammatory response and tissue
damage during the late phase of colitis pathogenesis.Without the induction of aggravated T cell inflammatory
responses, innate immunity may be able to keep the
commensal bacteria in check to prevent excessive tissue
damage. Such a scenario has been observed when com-
paring the colitis incidence between TCRα-/-, TCRβ-/-
and RAG1-/- mice housed in specific pathogen-free facil-
ity [27]. Alternatively, it is possible that the difference in
the timing of the deletion of the ppp4c gene may allow
the generation of colitogenic cells in the CD4cre:PP4f/f
thymus but not in the Lckcre:PP4f/f thymus. One such
candidate is NKT cells, whose maturation begins during
the DN-DP transition and is completed at the DP stage
[28] However, we did not find any significant alteration
in the percentages of CD3ε+CD49b+ NKT cells in gated
CD4+ and CD8+ populations in the CD4cre:PP4f/f mice
(Additional file 1: Figure S2C), although they did accu-
mulate in the gut of prolapsed animal (Figure 5B). Re-
sults from IEL T cell analyses in prolapse-free CD4cre:
PP4f/f mice (Figure 5 and S2B), from helper T cell
polarization (Figure 6C), and from the induction of experi-
ment colitis (Figure 6E) also helps rule out the possibility
that PP4 deficiency induces novel pro-inflammatory, coli-
togenic effector CD4 T cells. Nevertheless, such a possibil-
ity remains viable for other T cell subsets.
Treg deficiency caused by the ablation of PP4 is fairly
broad, encompassing defects in nTreg/iTreg differenti-
ation, suppressor functions and gut homeostasis. In this
context, PP4 may mediate these diverse effects either by
functioning through a single master factor that regulates
a complex network of downstream genes, or by acting




Figure 6 (See legend on next page.)
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Figure 6 PP4 deficient T cells are hypo-responsive to antigen stimulation, differentiate into Th17 cells ineffectively, and fail to induce
experimental colitis. A-B, Mice were immunized with KLH/CFA as described in the Materials and Methods. One wk later draining popliteal LN
cells were restimulated in vitro with KLH; the proliferation of responding T cells (A) and their cytokine secretion in culture supernatants (B) were
assessed on d 3 (n = 6). C, Naïve T cells were cultured in Th1-, Th2- or Th17-polarizaing conditions for 3 d, followed by intracellular cytokine
staining for measuring their polarization efficiency. Representative flow cytometry plots are shown. Statistical analyses results are shown (n = 4-7).
D-E, CD4+CD45RBhigh cells were sorted and transferred (4x105/mouse) into RAG1-/- mice (D). The recipients’ weight changes were monitored for 21 d
(E = 3, n = 5 ~ 6) (E). See Additional file 1: Figure S1 for flow cytometry gating strategies.
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regulation, the primary candidate that may be regulated by
PP4 is Foxp3. Evidence supporting a potential role of PP4
comes indirectly from recent reports showing that the sta-
bility of Foxp3 is reduced when its serine 19 residue is
phosphorylated by CDK2 [29], and that the activity of
Foxp3 is down-regulated when its serine 418 residue is de-
phosphorylated by protein phosphatase 1 [30]. However, in
either case the constitutive phosphorylation of these resi-
dues should enhance Foxp3 activity, yet our data indicate
that the loss of PP4 is manifested in the form of defective
Treg functions. In this regard, Foxp3 contains several other
potential serine/threonine phosphorylation sites on resi-
dues 13, 25, 114, 137 and 141 [31] that may serve as the
target of PP4-mediated dephosphorylation for the regula-
tion of Foxp3 activity. Alternatively, the Ikaros family tran-
scription factors, Eos and Helios, have been shown to
regulate the transcription [32] or activity of Foxp3 [33],
respectively. Our observation that the transcription and ex-
pression of Foxp3 are not significantly altered in PP4-
deficient Treg cells (Figure 3B-C) argues against a domin-
ant role for Helios, but potential PP4-mediated regulation
on Eos remains a possibility.
Other than Foxp3, the reduced Treg cell numbers may
also be caused by defective Treg cell survival or expan-
sion in the absence of PP4. This possibility is supported
by our previous report showing that the deletion of PP4
induces apoptosis in developing thymocytes [2] and by
the recent findings that the inhibition of PP4 blocks cell
cycle progression [34]. Alternatively, recent reports sug-
gest that Treg cells require proper TCR activation to
achieve optimal differentiation and homeostasis [35,36].
Since PP4 is shown to be involved in TCR signaling [2]
and NFκB activation [37], altered TCR activation may
also contribute to the Treg defects in the CD4cre:PP4f/f
mice. We are currently investigating these possibilities.
Conclusions
In this report, we have described the defects in Treg dif-
ferentiation, function and homeostasis caused by PP4
deficiency. These defects are associated with altered IL-10,
CTLA4, GITR and CD103 expression in PP4-deficient
Treg cells, and are accompanied by gut inflammation and
spontaneous colitis in the CD4cre:PP4f/f mice. While the
molecular mechanisms of PP4-mediated regulations onTreg cells remain to be elucidated, we believe that our
characterizations of the CD4cre:PP4f/f mice provide im-
portant frameworks for future studies on how PP4, and po-




PP4f/f [2], CD4cre [19], Foxp3-GFP [20] and RAG1-/-
[38] mice have been described. CD90.1 and CD45.1
C57/Bl6 congenic mice were obtained (Jackson labora-
tory). PP4f/f mice were crossed with CD4cre mice to
generate the CD4cre:PP4f/f mice with T cell-specific dele-
tion of the ppp4c gene. CD4cre:PP4f/f mice were further
crossed with Foxp3-GFP mice to generate the CD4cre:
PP4f/f:Foxp3-GFP mice. All mice were housed under
specific pathogen-free condition at the Laboratory Ani-
mal Center of the National Health Research Institutes
(NHRI). Mice with a loss of >20% body weight were re-
moved by euthanasia. All animal experimental proce-
dures followed the guidelines approved by the NHRI
Institutional Animal Care and Use Committee.
Antibodies and flow cytometric analysis
Antibodies against mouse epitopes of B220, CD3ε, CD4,
CD8, CD11b, CD25, CD39, CD45RB, CD49b, CD62-L,
CD90, CD223, CTLA4, CXCR5, GITR, Gr1, TCRβ,
TCRδ, TER119, IL-4, IL-6, IL-17A and IFNγ conjugated
with various fluorescent dyes or biotin, 7AAD and
AnnexinV-APC (all purchased from BioLegend or BD
Biosciences) were used for surface and intracellular
staining following standard protocols. CFSE (Invitrogen)
was loaded into targets cells following the manufac-
turer’s suggestions. Flow cytometry results were obtained
on 8-color FACSCanto II with FACSDiva software (BD
Biosciences), were and analyzed by FlowJo software
(Tree Star).
PCR and qPCR
For estimating the efficiency of ppp4c gene deletion, gen-
omic DNA was extracted from sorted primary cells with
standard protocols. Oligonucleotides for qPCR of exon 2
were 5′-GGGCGGTCCCAGAATCGAGT-3′ (primer a)
and 5′-ATCAGCTCGCAGCGCCGTAG-3′ (primer b).
For exon3, the oligonucleotides used were 5′-CCAGT
AB
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Figure 7 Analyses of factors that may contribute to the onset of colitis in the CD4cre:PP4f/f mice. A, Cells from various tissues were stained and
analyzed for lymphocyte marker expression. Percentages of CD4−CD8−B220−Gr1+ granulocytes in total cells are shown (n= 9-12). B, Prolapsed CD4cre:
PP4f/f mice were treated with antibiotic in drinking water (antibiotic-treated) or left untreated (sham-treated). Percent weight changes of these mice up
to 21 d are shown (E = 2, n= 3). C, Control or prolapse-free CD4cre:PP4f/f littermates were treated with 2% DSS in drinking water and monitored daily for
weight changes for 13 d. D-E, WT CD4+CD45RBhigh cells (4x105/mouse) were purified and co-transferred with sorted WT- or CD4cre:PP4f/f-Foxp3-GFP+
Treg cells (2x105/mouse, top panel, n= 4; 8x104/mouse, bottom panel, n= 10) into RAG1-/- mice (D). Recipients’ weight changes were monitored for 21 d
(E). See Additional file 1: Figure S1 for all flow cytometry gating strategies.
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and converted into cDNA with standard protocol. The
primers used are: Actin-1: 5′ AAGTGTGACGTTGAC











performed using FastStart Universal Probe Master Rox
(Roche Applied Science) on Realplex4 with Mastercycler
ep realplex software (Eppendorf ). Genotyping PCR
for the CD4cre transgene was performed with oligonu-
cleotides 5′-TCTCTGTGGCTGGCAGTTTCTCCA-3′
and 5′-TCAAGGCCAGACTAGGCTGCCTAT-3′. Geno-
typing of the PP4f allele was performed with oligonu-
cleotides 5′-TGCTCTGGTGCAGGAGATGTGTG-3′,
5′-ACGTGATTTGCGAAAGCCTCTCA-3′, and 5′-CTT
GGTAGAAGAGAGCAACGTGCAG-3′ in a three-primer
reaction. PCR conditions are available upon request.
Cell sorting and culture
For qPCR, Treg suppression assays and adoptive trans-
fer, cells were stained for surface markers and sorted on
FACSAria (BD Biosciences) or enriched by magnetic-
assisted cell sorting (MACS). All primary cells were cul-
tured in DMEM supplemented with 1 x non-essential
amino acid, 2 mM L-glutamine, 2 mM Glutamax, 1 mM
sodium pyruvate, 10 mM HEPES (all from Invitrogen),
10% FBS, 100 U/ml penicillin, 100 mg/ml streptomycin (all
from Biological Industries) and 125 μM 2-mercaptoethanol
(Sigma-Aldrich).
Histological analyses
Colons were excised, flushed with PBS, and fixed in 10%
formaldehyde for 1 hr before embedded in paraffin. Lon-
gitudinal or transverse sections were cut and stained
with haematoxylin and eosin with standard protocols.
Histological images were obtained on Olympus IX71
microscope with Olympus DP70 camera using Olympus
DP controller software (Olympus).
Isolation of IEL and LPL cells
Small intestines were harvested and flushed with CMF so-
lution (containing 2% FBS, 10 mM HEPES, Ca2+/Mg2+-free
HBSS) before removing the Peyer’s patches. Residualsmall intestine was cut into 0.5 cm pieces and washed six
more times with CMF solution, incubated in 10% FBS/
0.1 mM EDTA/CMF at 37°C for 15 min with rotary
shaking (220 rpm), transferred to a fresh tube, and vor-
texed for 15 sec at maximum setting. After the tissues
settled, supernatant was saved in a fresh tube. The pre-
cipitated tissues were re-applied in the above incubation/
transfer procedure for four more times. All supernatants
were pooled for IEL and epithelial cells isolation via Per-
coll gradient separation. The remaining intestine pieces
were washed four times with 10% FBS/5 mM EDTA/
CMF solution at 37°C for 15 min with rotary shaking
(220 rpm). After the last wash, the intestine pieces were
incubated in 10% FBS/ RPMI containing 100 U/ml type
VIII collagenase (Sigma-Aldrich) for 2 hr at 37°C with ro-
tary shaking (220 rpm) and media change at 1 hr. The
debris was allowed to settle, and the resulted super-
natant was subjected to Percoll gradient separation for
the isolation of LPL cells. Percoll (Sigma-Aldrich) gradi-
ent separation (for IEL: 44%/67%; for LPL: 40%/100%)
was performed by loading the supernatant atop of appro-
priate Percoll gradients, followed by centrifugation at
400g for 20 min and collection of IEL or LPL cells at the
interface.
Experimental colitis induction and antibiotics treatment
For adoptive transfer-induced experimental colitis, CD4
T cells were enriched from total splenocytes by MACS
negative selection for B220, CD11b, CD49b, CD8, and
Ter119. CD4+CD45RBhigh (upper 40% of CD45RB+ cells)
or CD4+CD25+Foxp3-GFP+ cells were purified from
these cells by sorting. Sorted cells were then transferred
via tail vein into RAG1-/- recipients as indicated in the
figure legend. For DSS-induced colitis, mice were ad-
ministered 2% DSS dissolved in sterilized drinking ad
libitum for 14 d. Animals were weighed daily and moni-
tored for rectal bleeding, diarrhea, and general signs of
morbidity. For antibiotics treatment, mice received
drinking water containing 0.66 mg/ml ciprofloxacin,
2.5 mg/ml metronidazole (Sigma-Aldrich) and 1.5% fruc-
tose (to encourage consumption) for 3 weeks. Control ani-
mals were given drinking water containing 1.5% fructose
only. Both DSS water and antibiotic solution were replaced
2-3 times weekly.
KLH immunization, T cell response and cytokine
measurement
Mice at 6-8 wk age were immunized in the hind footpad
with 0.1 ml of 1:1 emulsion of CFA (Difco) and 1 mg/ml
KLH (Sigma-Aldrich). One wk later draining popliteal
LN cells were harvested, labeled with CFSE, and restim-
ulated with titrating doses of KLH in vitro for 3 d. The
proliferation of responding cells was then measured by
CFSE dye-dilution, while the cytokine production was
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(eBioscience) following the manufacturer’s procedure.
Cytokine production from isolated IEL cells was assessed
similarly.
Treg/Th1/Th2/Th17 polarization and suppression assays
For in vitro polarization of Treg cells, naïve CD4+CD62-
L+ cells were purified by MACS from splenocytes and
stimulated with 1.6 μg/ml soluble anti-CD28 and plate-
bound anti-CD3ε in the presence of 5 ng/ml TGFβ,
10 μg/ml anti-IL-4 and 10 μg/ml anti-IFNγ for 3 d. Cells
were fixed in 4% paraformaldehyde/PBS prior to sur-
face staining and flow cytometry analyses with stand-
ard protocols. Th1 (5 ng/ml IL-2, 10 ng/ml IL-12
and 10 μg/ml anti-IL-4), Th2 (10 ng/ml IL-2, 4 ng/ml IL-4,
10 μg/ml anti-IFNγ and 10 μg/ml anti-IL-12) and Th17
(30 ng/ml IL-6, 1 ng/ml TGFβ, 10 μg/ml anti-IFNγ and
10 μg/ml anti-IL-4) cells were polarized and assessed
similarly. For Treg suppression assays, CD4 T cells were
enriched from pooled spleen and LN cells by MACS.
CD4+Foxp3-GFP+ Treg cells were then purified from
these cells by sorting. Irradiated APC were prepared
from C57Bl/6 splenocytes following red blood cell lysis and
200 Gray irradiation. WT responder T cells were prepared
from pooled spleen and LN cells from CD90.1 congenic
mice by MACS, and were loaded with CFSE. Cell culture
was set up in 96-well U-bottomed plates with 1 μg/ml
soluble-anti-CD3ε at a final volume of 200 μl, and con-
tained 5 × 104 WT responder cells, 2 × 105 irradiated
APC, and titrating number of Treg cells to obtain 1:1 to
16:1 ratio of responder : Treg cells. The proliferation of
WT responder T cells were assessed on d 3 by flow cytom-
etry; division index was calculated using the FlowJo soft-
ware (see Additional file 1: Figure S2D for more detail).
Statistical analyses
When applicable, data were plotted as mean ± SEM
with the p-values calculated using unpaired two-tailed
Student’s t-test.
Availability of supporting data
Gating strategies of flow cytometry analyses and additional
data are available as online supplemental materials in
Additional file 1.
CD4cre, CD4 promoter-driven Cre recombinase trans-
gene CD4SP, CD4 single-positive; DSS, dextran sulfate
sodium; E, number of independent experiment; IBD, in-
flammatory bowel disease; IEL, intra-epithelial lympho-
cyte; KLH, keyhole limpet hemocyanin; Lckcre, Lck
proximal promoter-driven Cre recombinase transgene;
LPL, lamina propria lymphocyte; LN, lymph node;
MACS, magnetic-assisted cell sorting; MLN, mesenteric
lymph node; NHRI, National Health Research Institutes;PP4, protein phosphatase 4; qPCR, quantitative PCR; Treg,
regulatory T.
Additional file
Additional file 1: Figure S1. Flow cytometry gating strategies. A,
Gating strategies for Figure 1A and 1C. B, Gating strategies for Figure 1B.
C, Gating strategies for Figures 1D, 2C, 3A and 3D. D, Gating strategies for
Figure 1E. E, Gating strategies for Figures 1F and 6C. F, Gating strategies
for Figure 2A and 6A. G, Gating strategies for Figure 5A and 5B. H, Gating
strategies for Figure 4F and 4G. Figure S2. Additional supporting results.
A, Peripheral T cells were purified by MACS, followed by western analyses
for the expression of PP4. Representative results from two experiments
are shown. Actin loading control is also shown. B, IEL cells were purified
as in the Materials and Methods and activated by 1.6 mg/ml plate-bound
anti-CD3e and anti-CD28 for 3 d. Culture supernatants were then analyzed
for the secretion of cytokines. C, Splenocytes from control or prolapse-free
CD4cre:PP4f/f mice were stained the respective markers and analyzed for
the percentage of CD4-CD8-B220-Gr1+ granulocytes (n=9-11). D, Calculation
of division index for the CFSE dye-dilution assay. In this example, the
generation numbers (0-6) are marked by the CFSE peaks. The total
number of cell division and the total number of starting cells represented
by all the generations are then calculated to obtain their ratio as the
division index. See the figure for more details.
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